Clinical trial

Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry

Recruiting now · Not applicable · 1 countries · Registry ID NCT04494048

Recruiting nowNot applicableObservational

What this study is about

The purpose of this registry study is to collect data through medical chart review and in patient visits on the efficacy and safety of various Endoscopic Bariatric therapies (EBTs). This is a retrospective and prospective, observational, medical chart review study for at least 6 standard of care visits up to 1 years after a subject consents for study participation.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 89 Years

SexAll

Healthy volunteersNot listed

ConditionObesity, Weight Loss, Gastro Esophageal Reflux, Bariatric Surgery Candidate

Full registry criteria

Inclusion Criteria: * Any patient who is considering undergoing EBT for weight loss within 6 months, or has undergone clinically indicated EBT for weight loss within the past 6 months * Above or equal to 18 years of age. Exclusion Criteria: * Any patient who has not undergone or will undergo EBT for weight loss * Below 18 years of age.

Treatments and study arms

Endoscopic Bariatric Therapies

Other

Participation in this study will allow for data collection through medical chart review for at least 6 standard of care visits up to 1 year after consenting to participate in this registry study. The exposure of interest is total body weight loss, safety and efficacy

Primary outcomes

Change of weight of the various bariatric therapiesBaseline, 1 month, 6 months, and 1 year post procedure

Compare mean percentage total body weight loss achieved via various Endoscopic Bariatric Therapies compared to baseline, 1 month, 6 months and 1 . year post procedure. This will be calculated by measuring the patients weight on a scale and comparing it to their baseline weight pre procedure.

Safety of procedure measured by in the number of adverse events of procedureat baseline

Number of adverse events; Type (unexpected, expected, related, possibly related), frequency and intensity of adverse events at baseline

Safety of procedure measured by in the number of adverse events that occur within 30 daysWithin 30 days of the procedure

Number of adverse events; Type (unexpected, expected, related, possibly related)

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Weill Cornell Medicine🇺🇸 New York, New York, United States

Open map

Reem Z Sharaiha, MDContact

Email · Call 6469622382

Andrea M Herr, NPContact

Email · Call 6469622382

Reem Z Sharaiha, MDPrincipal Investigator